Although prior research has focused on HSP function in cerebral ischemia–reperfusion injury, the potential for HSPs to reduce blood–brain barrier permeability by minimizing oxidative stress and suppressing inflammation offers promising therapeutic strategies for AD treatment as well. The gene discussed is HSP90B2P; the disease is Alzheimer disease.